Roivant Sciences Ltd (ROIV)
11.84
-0.04
(-0.34%)
USD |
NASDAQ |
Dec 13, 16:00
11.72
-0.12
(-1.01%)
After-Hours: 20:00
Roivant Sciences Profit Margin (Quarterly): -5.14K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Organon & Co | 22.69% |
| AstraZeneca PLC | 10.53% |
| Adaptimmune Therapeutics PLC | -43.07% |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -763.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 93.10% |
| Return on Assets | 82.08% |
| Return on Invested Capital | 87.50% |
| Gross Profit Margin (Quarterly) | 94.77% |
| Operating Margin (Quarterly) | -7.64K% |
| Return on Net Operating Assets | 1.42K% |